Vic Boddie

About Vic Boddie

Senior regulatory affairs, policy, and strategy executive with 12+ years of experience shaping science-based regulatory frameworks and advancing compliant approaches to advertising, promotion, and labeling across the pharmaceutical ecosystem. Brings deep FDA expertise and a proven ability to translate evolving regulatory expectations and enforcement trends into actionable strategies that support product launch, lifecycle management, and patient access.Dr. Boddie is recognized for building and executing enterprise-level regulatory engagement strategies that align scientific rigor, public health priorities, and business objectives. His leadership spans promotional review, labeling strategy, risk assessment, and regulatory policy development, with extensive experience advising cross-functional stakeholders on compliant product and disease-state communications.As a trusted liaison between FDA and industry, Dr. Boddie leads regulatory meetings with sponsors and partners with public health agencies, legislative bodies, and pharmaceutical trade organizations to drive regulatory clarity and consistency. As a member of FDA’s Artificial Intelligence Council, he spearheads the integration of emerging technologies to enhance regulatory efficiency and execution. Known for strategic leadership and external influence, Dr. Boddie aligns diverse stakeholders around shared goals that strengthen regulatory predictability, mitigate promotional and labeling risk, and modernize regulatory practice in support of innovation.

Experience

1. Branch Chief, Division of Drug Compliance

   FDA

   Oct 2020 — Present · Washington, DC, US

Education

• Hampton University

  Bachelor of Science (BS)

• Howard University

  Doctor of Philosophy (Ph.D.)